sesisili

Police had fired 40 shotgun rounds, 22 rubber bullets, 42 teargas shells and 11 teargas grenades to disperse the violent mob in Navi Mumbai, an official had said. Internet services were suspended in Navi Mumbai as a precautionary measure on Thursday. Hospital Dean Dr Mukund Tayade told PTI that 25-year-old Rohan Todkar had sustained multiple injuries on his head, hands and legs during the violence at Kopar Khairane on Wednesday.

 Also Read: Maratha group calls off quota protest in Mumbai, bandh endsOver 150 vehicles, including 20 belonging to police, were damaged in the violence. The agitation, however, turned violent after a 27-year-old protester jumped to his death in Godavari river near Aurangabad on July 23. Around 20 policemen, including eight officers, were injured in stone-pelting by protesters at Kopar Khairane and Kalamboli in Navi Mumbai on Wednesday during the bandh called by Maratha organisations to demand quota for the community in government jobs and education.

The community had earlier taken out silent marches across the state to highlight their demands, prominent among them being China auto door seal that of reservation. Nine persons were injured when police caned protesters and fired pellets and rubber bullets on the violent mob, police had said. He was shifted to J J Hospital on Thursday and was kept in the intensive care unit, but succumbed to his injuries, Tayade said. Marathas, a politically influential community that constitutes around 30 per cent of the states population, have been demanding 16 per cent reservation.Mumbai: A protester, who was injured in the violence during the Maratha quota stir in adjoining Navi Mumbai, has succumbed to his injuries at the government-run JJ Hospital here.

The proposal was pending before the Foreign Investment Promotion Board (FIPB) which has been abolished now.While US-based retail giant Amazon China wholesale silicone rubber is one of the major e-commerce players in India, Grofers and Big Basket are into online grocery space.As per the proposal, the company will open a wholly- owned subsidiary in India to carry out the business.

The government has approved American e-commerce major Amazon’s proposed $ 500 million investment in retailing of food products in India, an official said.The government last year allowed 100 per cent foreign direct investment (FDI) through approval route for trading, including through e-commerce, in respect of food products manufactured and produced in India.

As per norms, a foreign company can open a wholly-owned subsidiary in India to retail food products produced and or manufactured in the country by way of opening stores or online.Under the new mechanism, proposals related to retail sector is being approved by the commerce and industry ministry.The Union Cabinet last month decided to wind up the 25- year-old FIPB, which had been vetting FDI proposals requiring government approval, to expedite the clearance process.

Amazon has proposed to invest around $ 500 million in retail of food products.Hence, the Department of Industrial Policy and Promotion (DIPP) gives the green signal to the proposal.Currently, the government permits 100 per cent direct investment (FDI) in the food processing sector.The government had received investment proposals from three companies - Amazon, Grofers and Big Basket - worth $ 695 million for retail of food products.In 2016-17 (April-December), the food processing sector in the country received FDI of $ 663. It will stock food products and sell online.23 million.

The newly-framed Food Safety and Standards (Health Supplementaries, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations 2016 stresses the need for scientific scrutiny before such claims are made and labelled on products. Importantly, they can claim their products have health benefits only if there is scientific evidence that these actually work.

Based on the evidence, the manufacturers will also have to use a auto rubber Suppliers disclaimer that a certain product is "shown to be helping in keeping your heart healthy". New regulations issued by the Food Safety and Standards Authority of India (FSSAI) make it mandatory for all those selling food items for dietary use, food for special medical purposes, health supplements, novel food and nutraceuticals to declare the nutritional benefits on their products.Significantly, FSSAI prohibits implied claims like that a product will cure a certain disease, or claims of drug-like efficacy like "prevents bone fragility in post-menopausal women". This will have to be used on the product when a single human intervention study shows a significant benefit. The new regulations also prohibit the manufacturers from making tall claims that their products can cure diseases or have drug-like efficacy.

Under this, to claim ingredients, nutrients or nutritional value in respect of an article of food for "enhanced function" and "disease risk reduction", the manufacturers will have to make available scientific literature, including official traditional texts, and post market data or consumer studies or cohort or retroactive studies based on the eating patterns and health benefits, epidemiological international and national data and other well documented data, that will be reviewed by the food authority before labelling.

However, the word "proven" can only be used if more than one human intervention study studies or epidemiological evidence on the Indian population have been provided, such as that this product is "proven" to make you lose weight.Valid and scientific data will also be a pre-requisite for manufacturers making "heart healthy" claims.New Delhi: Food manufacturers will no longer be use misleading claims to trick people into buying their products.

State finance minister Sudhir Mungantiwar and Baba Ramdev will meet on Tuesday where the primary draft of partnership between Future Group and the forest department of the state will probably be discussed. The party’s spokesperson Sachin Sawant claimed that products derived from forests are a national asset and that an intention to sell them to Ramdev is an indication that the government is returning the baba’s "pre-election favours.

"Products derived from forests are a national asset and has immense potential. A part of the goods is already being sold through retail shops. He has given us a buy back quantity, which nobody else does," Mr Mungantiwar said. "There are 5,250 plant species available in the state, out of which 2242 are known for their medicinal properties," the official said.

But, we do not want to let China auto door seal Suppliers go of the chance to sell excessive products in a bulk quantity."For instance, honey and certain medicines derived exclusively from certain trees can be sold to Baba Ramdev since we have the capability to manufacture them in a large quantity but we do not currently have a market for it," he added. "We want to increase production for our ‘Van Dhan Jan Dhan’ scheme."Mr Sawant alleged that if Ramdev were brought into the picture, tribals would be exploited to benefit people who helped Prime Minister Narendra Modi come to power. Thus, we intend to sell these them as raw products to Baba Ramdev.Mr Mungantiwar will hold a meet with Ramdev on Tuesday and discuss future tie-up possibilities in the regard.. These products, if marketed properly, can fetch much better returns than what any baba can give," he said.

However, it is not yet decided whether state’s forest produce will sold under the Patanjali brand or not. Meanwhile, an official from the forest department said that the total area under forests in the state is 61,579 sq km and covers around 20 per cent of Maharashtra’s geographical area.The state forest ministry is considering tying up with Baba Ramdev’s Patanjali in order to expand the market of herb products from the state’s forests.Meanwhile, the move has not gone down well with Congress

The homegrown ayurvedic products maker, which gets about 30 per cent of its revenues from international operations through offline distribution network, has a presence in over 120 countries.in about a month back and many of its products are already best-sellers on the e-commerce platform.He added that the partnership will help Dabur tap into demand from the Indian diaspora as well as local Americans.

"As part of the Global Selling Programme, Amazon will help provide Dabur a marketplace to showcase its vast range of products to global consumers," Amazon India Director and GM Gopal Pillai said. Besides, Amazon is working with brands like Liberty, Fabindia, Biba and Titan to take them to international audiences.

FMCG major Dabur has partnered with e-commerce giant Amazon to make over 30 of its products available to customers in the silicone rubber Suppliers US, Canada and Mexico as it looks to further strengthen its international play. Amazon has a wider reach and will help us expand our footprint exponentially," Dabur India Executive Director (Consumer Care Business) Krishan Kumar Chutani told reporters here.

About 30 per cent of our business is international..."There is a huge demand for ayurvedic, chemical-free products in the international markets."Depending on the response we get, we intend to launch 80 more products in the next quarter," he said, adding that the company is also introducing an exclusive product Himalaya Honey that will be sold through Amazon.Recently, Dabur got listed as a seller on Amazons India portal to sell its products in the country.As a part of Amazons global seller programme, Dabur initially will take around 30 of its products like Vatika hair oil, Chyawanprash and toothpaste to the US market.Chutani said the company had started working with Amazon.com.He added that there are 26,000 sellers from India that are a part of this programme

The acquisition was made by Cipla (EU) through a wholly- owned special purpose vehicle which would merge into InvaGen Pharmaceuticals after the acquisition, Cipla said in a BSE filing.Pharmaceutical firm Cipla today announced that its UK arm, Cipla (EU) has closed the USD 550 million deal to acquire two US-based firms, InvaGen Pharmaceuticals and Exelan Pharmaceuticals.75 in the mid-day trade, up 0.78 per cent from the previous close on BSE.The acquisition made by Cipla through a wholly- owned special purpose vehicle which would merge into InvaGen Pharmaceuticals.In addition, InvaGen has filed five first-to-file products.

Dosage forms include immediate release, modified release and extended release tablets and capsules.

In September the company had announced that it would acquire the two US-based companies owned by one of the promoters of Hetero Group in an all cash transaction of USD 550 million (approx Rs 3,650 crore).Shares of Cipla were trading at Rs 523.The acquisition of InvaGen pharmaceuticals also provides Cipla with about 40 approved ANDAs, 32 marketed products, and 30 pipeline products which are expected to be approved over the next 4 years, the company said. Cipla said the combined revenue for the two US-based firms for the year-ended 2015 is over USD 230 million.

Cipla Global Chief Operating Officer Umang Vohra said:"The acquisition will further strengthen Cipla's presence in the US pharmaceutical market.InvaGen's balanced portfolio, robust manufacturing base and strong R&D capabilities will act as lever to expand Cipla's reach in the US market."The company said the acquisition will give scale to its US business, currently 8 per cent of total revenue as well as providing silicone rubber Suppliers a launchpad to introduce Cipla's pipeline of products in respiratory and injectables, among others, in the coming years. Combined with the pipeline of InvaGen products, the overall portfolio will be wide-ranging and will cover chronic therapies like CVS, CNS, respiratory, oncology and diabetes among others.

InvaGen has three units located in Long Island, NY, with a total production capacity of 12 billion tablets and capsules per annum and about 500 employees.The acquisition is second major buyout by Cipla in its 80 year history after the takeover of Cipla Medpro, South Africa.With this acquisition, Cipla will have more relevance to wholesale and retail customers, the company added